Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03820193 · ClinicalTrials.gov registry record · Early Phase 1
Nonopioid Analgesia After Arthroscopic Meniscus Surgery
A Early Phase 1 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 61
- Enrollment target
NCT03820193 is a Early Phase 1 study that has completed, run by Henry Ford Health System. The registered enrollment target is 61 participants.
The verdict
NCT03820193, a Early Phase 1 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 61 participants
- Enrollment target
Study Summary
This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of arthroscopic meniscus surgery: a treatment group given a non-opioid pain control regimen, and a standard of care control group given standard opioid pain control regimen
Interventions
- DRUG Acetaminophen
- DRUG Ketorolac
- DRUG Celecoxib
- DRUG Gabapentin
- DRUG Hydrocodon/Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2019-01-22 |
| Est. Completion | 2021-01-20 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03820193
The ClinicalTrials.gov registry entry for NCT03820193 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT03820193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03820193 about?
NCT03820193 is a clinical study titled "Nonopioid Analgesia After Arthroscopic Meniscus Surgery". This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of arthroscopic meniscus surgery: a treatment group given a non-opioid pain control regimen, and a standard of care control grou...
What is the current status of trial NCT03820193?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 61 participants. The study started on 2019-01-22. Estimated completion is 2021-01-20.
What interventions are being tested in trial NCT03820193?
The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Celecoxib (DRUG), Gabapentin (DRUG), Hydrocodon/Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT03820193?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.